CVE:VPT VentriPoint Diagnostics (VPT) Stock Price, News & Analysis C$0.16 +0.02 (+10.71%) As of 07/11/2025 03:57 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesInsider TradesBuy This Stock About VentriPoint Diagnostics Stock (CVE:VPT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get VPT alerts:Sign Up Key Stats Today's RangeC$0.14▼C$0.1750-Day RangeC$0.10▼C$0.1652-Week RangeC$0.08▼C$0.22Volume366,359 shsAverage Volume201,270 shsMarket CapitalizationC$25.14 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada. Read More Receive VPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VentriPoint Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address VPT Stock News HeadlinesVentripoint Diagnostics Ltd. (VPT.V) - Yahoo FinanceJune 26, 2025 | finance.yahoo.comWhen AI Meets Heart Care: The FDA Just Cleared A Revolutionary Cardiac Imaging Device. Here’s What You Should KnowMarch 15, 2025 | theglobeandmail.comTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.July 12 at 2:00 AM | Porter & Company (Ad)VentriPoint Diagnostics Launches Private Placement to Bolster OperationsMarch 14, 2025 | tipranks.comShares Of AI Company Surging On FDA 510(k) Clearance NewsFebruary 27, 2025 | msn.comVentripoint Diagnostics Announces U.S. FDA 510(k) Clearance for VMS+(TM) 4.0 Automated Radiological Image Processing Software/SystemFebruary 27, 2025 | finance.yahoo.comVentripoint refines AI-powered heart scanner submission to FDAJanuary 21, 2025 | msn.comVentriPoint Completes Second Tranche of Convertible Debenture OfferingJanuary 20, 2025 | tipranks.comSee More Headlines VPT Stock Analysis - Frequently Asked Questions How have VPT shares performed this year? VentriPoint Diagnostics' stock was trading at C$0.10 at the beginning of 2025. Since then, VPT stock has increased by 55.0% and is now trading at C$0.16. How do I buy shares of VentriPoint Diagnostics? Shares of VPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of VentriPoint Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some other companies that VentriPoint Diagnostics investors own include Resverlogix (RVX), Meta Platforms (META), Sphere 3D (ANY), Aptose Biosciences (APTO), Antibe Therapeutics (ATE), AuRico Gold Inc. Ordinary Share (AUQ) and Baytex Energy (BTE). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolCVE:VPT CIKN/A Webwww.ventripoint.com Phone416-848-4156FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$5.25 million Net Margins-3,732.10% Pretax MarginN/A Return on Equity388.60% Return on Assets-136.72% Debt Debt-to-Equity Ratio-58.56 Current Ratio0.28 Quick Ratio6.67 Sales & Book Value Annual SalesC$140.67 thousand Price / Sales178.73 Cash FlowC$0.03 per share Price / Cash Flow5.53 Book ValueC($0.02) per share Price / Book-9.92Miscellaneous Outstanding Shares162,204,000Free FloatN/AMarket CapC$25.14 million OptionableNot Optionable Beta0.39 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (CVE:VPT) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VentriPoint Diagnostics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share VentriPoint Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.